FDA Issues Warning Letter to Fresenius Kabi's Melrose Park Facility, Impacting FMS Stock
· gurufocus.com
On September 29, 2026, the U.S. Food and Drug Administration (FDA) issued a warning letter to Fresenius Kabi concerning serious regulatory violations at its Mel
On September 29, 2026, the U.S. Food and Drug Administration (FDA) issued a warning letter to Fresenius Kabi concerning serious regulatory violations at its Mel...